Safety and outcome of allogeneic stem cell transplantation in myelofibrosis-Reference-Cited by-同舟云学术

Safety and outcome of allogeneic stem cell transplantation in myelofibrosis

Published:2015-05-06 Issue:3 Volume:96 Page:222-228
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Markiewicz Miroslaw¹,Dzierzak Mietla Monika¹,Wieczorkiewicz Agata¹,Mizia Sylwia²,Helbig Grzegorz¹,Kopera Malgorzata¹,Bialas Krzysztof¹,Rybicka Malwina¹,Matyja Mariusz¹,Koclega Anna¹,Sedlak Lech³,Oleksy Tomasz³,Raman Sundar³,Kyrcz-Krzemien Slawomira¹

Affiliation:

1. Department of Hematology and Bone Marrow Transplantation; School of Medicine in Katowice; Medical University of Silesia; Katowice Poland

2. Department of Public Health; Department of Organisation and Management; Faculty of Health Science; Wroclaw Medical University; Wroclaw Poland

3. School of Medicine in Katowice; Medical University of Silesia; Katowice Poland

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12572/fullpdf

Reference19 articles.

1. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment;Cervantes;Blood,2009

2. Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib;Jaekel;Bone Marrow Transplant,2014

3. Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors;Gupta;Blood,2012

4. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia;Kerbauy;Biol Blood Marrow Transplant,2007

5. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO);Patriarca;Haematologica,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplant Outcomes in Myelofibrosis: Impact of Donor Type [Cord Blood Grafts Supported by CD34+ selected Cells (Haplo-Cord) vs Matched Donors];Transplantation and Cellular Therapy;2024-09

2. Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups;Biology of Blood and Marrow Transplantation;2019-08

3. Primary myelofibrosis: current therapeutic options;Revista Brasileira de Hematologia e Hemoterapia;2016-07